HomeStrategyA $435 Million Bet on ‘Reversing Aging’

A $435 Million Bet on ‘Reversing Aging’

Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that rewinds cellular aging in the liver. 

Must Read

spot_img